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PROTOCOL OPEN
Systematic scoping review protocol of methodologies of
chronic respiratory disease surveys in low/middle-income
countries
Dhiraj Agarwal 1, Nik Sherina Hanaﬁ 2, Soumya Chippagiri3, Evelyn A. Brakema 4, Hilary Pinnock5, Ee Ming Khoo 2, Aziz Sheikh5,
Su-May Liew2, Chiu-Wan Ng2, Rita Isaac3, Karuthan Chinna2, Wong Li Ping 2, Norita Binti Hussein2, Sanjay Juvekar 1 and the RESPIRE
Collaborators
This protocol describes a systematic scoping review of chronic respiratory disease surveys in low/middle-income countries (LMICs)
undertaken as part of the Four Country ChrOnic Respiratory Disease (4CCORD) study within the National Institute for Health
Research Global Health Research Unit on Respiratory Health (RESPIRE). Understanding the prevalence and burden of chronic
respiratory disease (CRD) underpins healthcare planning. We will systematically scope the literature to identify existing strategies
(deﬁnitions/questionnaires/diagnostics/outcomes) used in surveys of CRDs in adults in low-resource settings. We will search
MEDLINE, EMBASE, ISI WoS, Global Health and WHO Global Health Library [search terms: prevalence AND CRD (COPD, asthma) AND
LMICs, from 1995], and two reviewers will independently extract data from selected studies onto a piloted customised data
extraction form. We will convene a workshop of the multidisciplinary 4CCORD research team with representatives from the RESPIRE
partners (Bangladesh, India, Malaysia, Pakistan and Edinburgh) at which the ﬁndings of the scoping review will be presented,
discussed and interpreted. The ﬁndings will inform a future RESPIRE 4CCORD study, which will estimate CRD burden in adults in
Asian LMICs.
npj Primary Care Respiratory Medicine           (2019) 29:17 ; https://doi.org/10.1038/s41533-019-0129-7
BACKGROUND
Chronic respiratory diseases (CRDs), especially asthma and chronic
obstructive pulmonary disease (COPD), are common public health
problems across the world, with the Global Burden of Disease
estimating that CRDs now account for 30% of total deaths.1
Although morbidity and mortality are particularly high in low- and
middle-income countries (LMICs), there are very little robust data
on the true prevalence of asthma and COPD in these countries.2,3
Chronic respiratory symptoms are common in the general
population,1 but the clinicians in primary healthcare systems in
resource-poor countries lack the skills and support to diagnose the
underlying disease condition.4–8 Factors contributing to low rates
of diagnosis include limited awareness of respiratory long-term
conditions,4–10 limited access to healthcare and lack of diagnostic
capability in these countries.11 Determining the prevalence of
asthma and COPD remains a challenge because of the poor
sensitivity and speciﬁcity of the widely used questionnaire-based
research tools,3,12 while objective testing with spirometry may be
a challenge in community-based epidemiological surveys.11
With notable exceptions, such as the Burden of Lung Disease
(BOLD),13 surveys of the prevalence of CRDs conducted in LMICs
often have major limitations (such as relying on patient-reported
disease or symptom questionnaires), and report very varied
estimates of prevalence.2,14–39 In addition, many existing surveys
focus on one condition (e.g. the BOLD study detects COPD,13 the
International Study of Asthma and Allergies in Childhood (ISAAC)
detects symptoms of asthma and allergy in children40) and rarely
look for the broad range of less common causes of CRD (such as
interstitial lung disease, bronchiectasis, lung cancer and complica-
tions post tuberculosis) or attempt to identify the phenotypes of
asthma and COPD, which are increasingly regarded as important
to understanding and managing the conditions.41
Effective health policies related to CRD can only be developed if
we know the true burden of asthma, COPD and other CRDs in the
community. Funded by the National Institute for Health Research
(NIHR), RESPIRE is a Global Health Research Unit focusing on
respiratory health in Asia (https://www.ed.ac.uk/usher/respire).
Prior to undertaking a comprehensive Four Country ChrOnic
Respiratory Disease study (4CCORD) in the partner countries of
RESPIRE, we sought to systematically scope the literature to
identify existing strategies—that is, deﬁnitions, questionnaires,
study tools and diagnostics protocols—that have been used to
conduct surveys for CRDs in LMICs.
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METHODS
A systematic scoping review aims to ‘map the key concepts underpinning
a research area and the main sources and types of evidence available’.42 As
such, scoping reviews typically address broad questions, potentially
include a range of methodologies and do not undertake quality
assessment. This contrasts with the focused question of a systematic
review, which is answered from a relatively narrow range of quality-
assessed studies.42
Systematic review procedures, as described in the Cochrane Handbook
for Systematic Reviews of Interventions,43 have been adapted to meet the
needs of a scoping review.44,45 We will follow the six-step framework
described by Arksey and O’Malley42 and subsequently widely endorsed
and enhanced in methodological literature.45–47
Identifying the research question
The aim of this review is to scope published epidemiological CRD surveys
to identify their aims, methodologies and outcomes in order to identify
evidence gaps and inform the methodology of the proposed RESPIRE
4CCORD survey on the burden of CRD. Our objectives are therefore to
answer the following research questions:
1. What surveys on the prevalence of asthma, COPD and other CRDs
have been undertaken in resource-poor settings?
2. What deﬁnitions, questionnaires, tests, diagnostic processes and
outcomes did the surveys employ?
3. How was the socio-economic burden (from a societal or healthcare
perspective) of asthma, COPD and other CRDs estimated in these
surveys?
4. What strategies have been used to identify phenotypes of asthma
and COPD, or to identify the causes of ‘other CRD’?
Identifying relevant studies
We will search MEDLINE, EMBASE, ISI Web of Science, Global Health and
WHO Global Health Library using search terms for prevalence AND CRD
(COPD OR asthma OR CRD) AND LMICs/low-resource settings, from year
1995 onwards when publication of the Global Initiative for Asthma
(GINA),48 followed by the Global Initiative for Chronic Obstructive Lung
Disease (GOLD) guidelines for COPD,49 provided internationally agreed
deﬁnitions and diagnostic strategies for the two most common CRDs. The
detailed MEDLINE search strategy is shown in Supplementary Table 1.
Key websites (e.g. http://ghdx.healthdata.org) will be checked for
eligible studies. We will follow up references of surveys with methodolo-
gical papers, and will group papers from the same study (e.g. BOLD,13
FRESH AIR4). To avoid overlooking relevant local studies, we will not
impose language restrictions; translations will be undertaken where
possible.
Study selection
Selection criteria and deﬁnitions are detailed in Table 1. Our focus is on
surveys conducted in LMICs to study the prevalence of CRD (speciﬁcally
asthma and COPD but also other CRDs) in randomly sampled community-
based populations of adults. We anticipate that these will incorporate
assessment of chronic respiratory symptoms and objective tests, measure-
ment of risk factors for CRD, phenotypes of asthma/COPD or individual,
healthcare or societal burden of CRD. We will undertake training at each step
(100 randomly selected titles/abstracts or 50 full-text papers will be screened
independently by D.A., N.S.H., H.P., E.M.K. and S.J.; they will be repeated until
agreement exceeds 90%). After an initial shift to exclude obviously irrelevant
titles (D.A., N.S.H.), two reviewers (D.A., N.S.H., S.C., S.-M.L. or E.A.B.) will screen
the titles and abstracts, and then undertake full-text screening of potentially
relevant papers, with disagreements resolved by discussion between
researchers, arbitrated by a third reviewer (H.P., E.M.K. and S.J.) if necessary,
and involving the wider research group to agree on conventions that
operationalise the inclusion/exclusion criteria (see Table 1). The selection
process will be undertaken using EndNote software (v9.0) and summarised
using a PRISMA ﬂow diagram.
Charting the data
Two reviewers (D.A., N.S.H., S.C., S.-M.L. or E.A.B.) will independently
extract data onto a piloted customised data extraction form as follows:
study metadata, country and populations, sampling strategy, CRD
deﬁnitions, survey procedure (questionnaires used, spirometry and
other measurements), risk factors measured, assessments of individual,
societal and health service burden of disease and detection of
phenotypes. Our research questions focus on identifying the process
(rather than the outcomes) of undertaking surveys of CRD in LMICs,
though we will note the prevalence of asthma, COPD and any other CRD
identiﬁed in the included studies in order to inform future sample size
calculations.
We will attempt to contact authors of the included papers for missing or
unclear essential information; speciﬁcally, we will request copies of
questionnaires or study procedures if they are not otherwise available.
Multiple publications from the same study will be grouped, and draw on all
the relevant publications, including methodological papers.13
Collating, summarising and reporting the results
We will tabulate the procedures used and identify
● The strategies used to identify randomly sampled populations
in LMICs
● The disease deﬁnitions used (which may vary over time)
● The questionnaires used and tests performed to detect asthma, COPD
and/or other CRD
Table 1. Inclusion and exclusion criteria
Criterion Deﬁnition
Population Populations of adults (typically of over 18 years, but we will accept different thresholds, for example, reﬂecting the age of the
majority in different countries). Surveys that also screened children will be included if the procedure for adults is described
Screening procedure Surveys employing random sampling with the aim of determining the prevalence of asthma,50 COPD51 or other CRD8 in the
adult population. The survey procedures may include questionnaires, clinical examination, spirometry and/or other tests. We
are also interested in the prevalence of chronic respiratory symptoms, and in surveys that detected phenotypes
Disease deﬁnitions We will include studies that use deﬁnitions of CRD from globally recognised guidelines: asthma,50 COPD 51 or other CRD8
We deﬁne ‘chronic’ respiratory symptoms as symptoms (such as cough, wheezing and shortness of breath) that have persisted
for more than 3 months, or recurred in ‘attacks’
Burden of disease We are interested in the population-level surveys of the burden of CRD; this includes symptom burden, use of healthcare
resources or societal burden (e.g. absenteeism, loss of earnings)
Phenotypes We are interested in population-level surveys that have attempted to detect phenotypes of asthma,50 COPD51 or the overlap
between these conditions53 in the context of low-resource settings
Setting Normally LMICs. Our, focus is surveys undertaken in low-resource contexts, which we anticipate will normally be countries
classiﬁed by the Organisation for Economic Cooperation and Development as being ‘LMIC’ at the time of the survey. We may,
however, include surveys developed in higher-income countries if the methodology employed was subsequently used in low-
resource settings (e.g. BOLD)
Study designs Prevalence surveys, including protocols for surveys
COPD chronic obstructive pulmonary disease, CRD chronic respiratory disease, LMICs low- and middle-income countries, BOLD Burden of Lung Disease
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● Other variables for which information is collected in the included
studies, in order to assess individual, societal and healthcare burden of
CRD, and the risk factors for disease
● Whether recent surveys have addressed contemporary understanding
of asthma/COPD phenotypes41,50,51 and the variables assessed to
achieve this in low-resource settings
Consultation
We will convene a workshop of the multidisciplinary research team with
representatives from the RESPIRE partners (from Bangladesh, India,
Malaysia, Pakistan and Edinburgh), at which the ﬁndings of the scoping
review will be presented, discussed and interpreted. The conclusions will
inform a future RESPIRE 4CCORD study, which will aim to estimate CRD
burden in adults in Asian LMICs (initially Bangladesh, India, Malaysia and
Pakistan).
Dissemination
We will publish our ﬁndings in a peer-reviewed journal following the
reporting standards for scoping reviews (PRISMA-ScR)52 and disseminate
widely through our stakeholder groups and using innovative media
approaches.
DISCUSSION
Assessment of the true prevalence for asthma, COPD and other
CRDs underpins healthcare planning. Policymakers need assess-
ments of the burden of disease if they are to plan and resource
services that can accurately diagnose and effectively reduce the
burden of CRD. Communication of the burden of CRD will raise
awareness amongst stakeholders of the individual and societal
impact of respiratory conditions and highlight the importance to
communities of addressing potentially modiﬁable risk factors.
Limitations in currently available estimates of CRD burden in
South Asian countries (e.g. relying on symptom questionnaires, or
patient-reported diagnoses), hamper advocacy and are a barrier to
development of healthcare service. Our scoping review will
identify existing strategies used in surveys in LMICs, enabling
future surveys to optimise their methodology and provide robust
estimates of disease burden.
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